XILIO THERAPEUTICS INC
COM · CUSIP 98422T100
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.95.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 30 |
| Q4 2022 | 29 |
| Q1 2023 | 33 |
| Q2 2023 | 33 |
| Q3 2023 | 32 |
| Q4 2023 | 35 |
| Q1 2024 | 32 |
| Q2 2024 | 33 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 8 | 7 |
| Q1 2023 | 11 | 3 |
| Q2 2023 | 5 | 8 |
| Q3 2023 | 7 | 10 |
| Q4 2023 | 13 | 7 |
| Q1 2024 | 11 | 13 |
| Q2 2024 | 16 | 12 |
Biggest buyers
| Rock Springs Capital Management LP | Added | +1.6m |
| Bain Capital Life Sciences Investors, LLC | Added | +980.0k |
| MORGAN STANLEY | Added | +447.0k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +98.0k |
| RENAISSANCE TECHNOLOGIES LLC | Added | +45.6k |
| RAYMOND JAMES & ASSOCIATES | New | +38.8k |
| XTX Topco Ltd | New | +33.3k |
| STATE STREET CORP | Added | +27.7k |
| Avantax Planning Partners, Inc. | New | +25.0k |
| NORTHERN TRUST CORP | Added | +21.4k |
Biggest sellers
| Atlas Venture Life Science Advisors, LLC | Sold out | -992.9k |
| FMR LLC | Reduced | -511.8k |
| Balyasny Asset Management L.P. | Reduced | -66.1k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -58.0k |
| PFG Investments, LLC | Sold out | -30.0k |
| PRELUDE CAPITAL MANAGEMENT, LLC | Sold out | -29.5k |
| FNY Investment Advisers, LLC | Sold out | -27.5k |
| Summit Trail Advisors, LLC | Sold out | -16.0k |
| Tower Research Capital LLC (TRC) | Reduced | -6.9k |
| JPMORGAN CHASE & CO | Reduced | -5.4k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| GILEAD SCIENCES, INC. 13G · passive investor no change · filed 2026-02-12 | 19.9% |
| Coastlands Capital LP 13G · institution new · filed 2025-12-11 | 10.0% |
| Sirenia Capital Management LP 13G · institution new · filed 2026-05-15 | 9.9% |
| AbbVie Inc. 13G · passive investor new · filed 2025-02-18 | 9.0% |
| Bain Capital Life Sciences Fund II, L.P. 13G · passive investor filed 2026-02-17 | 8.5% |
| STEMPOINT CAPITAL LP 13G · institution +1.2 pts · filed 2026-02-17 | 8.4% |
| Frazier Life Sciences Public Fund, L.P. 13G · passive investor -3.2 pts · filed 2026-02-13 | 6.7% |
Fell to 5% or below in the last year: Point72 Asset Management, L.P. (0.0%, 2026-05-15)
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC 0.39% of their portfolio | 3.8m $3.6m | Added +980.0k |
| Rock Springs Capital Management LP 0.09% of their portfolio | 3.0m $2.8m | Added +1.6m |
| TAKEDA PHARMACEUTICAL CO LTD 0.60% of their portfolio | 1.5m $1.4m | Unchanged |
| RiverVest Venture Management LLC 20.01% of their portfolio | 1.4m $1.4m | Unchanged |
| FMR LLC 0.00% of their portfolio | 1.4m $1.3m | Reduced -511.8k |
| MORGAN STANLEY 0.00% of their portfolio | 1.1m $1.1m | Added +447.0k |
| VANGUARD GROUP INC 0.00% of their portfolio | 902.5k $855.1k | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 295.0k $279.5k | Added +45.6k |
| Balyasny Asset Management L.P. 0.00% of their portfolio | 272.5k $258.2k | Reduced -66.1k |
| FIL Ltd 0.00% of their portfolio | 218.7k $207.2k | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 182.9k $173.3k | Added +98.0k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 71.1k $67.3k | Unchanged |
| BlackRock Inc. 0.00% of their portfolio | 66.4k $62.9k | Added +21.1k |
| STATE STREET CORP 0.00% of their portfolio | 43.4k $41.1k | Added +27.7k |
| SevenBridge Financial Group, LLC 0.01% of their portfolio | 41.0k $37.2k | Added +10.0k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 39.2k $37.1k | Added +21.4k |
| RAYMOND JAMES & ASSOCIATES 0.00% of their portfolio | 38.8k $36.8k | New |
| XTX Topco Ltd 0.00% of their portfolio | 33.3k $31.5k | New |
| Avantax Planning Partners, Inc. 0.00% of their portfolio | 25.0k $23.7k | New |
| TWO SIGMA SECURITIES, LLC 0.00% of their portfolio | 13.3k $12.6k | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 12.2k $11.6k | Reduced -58.0k |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio | 11.9k $11.3k | Unchanged |
| Dunhill Financial, LLC 0.01% of their portfolio | 10.3k $9.7k | Unchanged |
| Pinnacle Financial Group, LLC / IL 0.00% of their portfolio | 10.0k $9.5k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 4.2k $4.0k | Reduced -6.9k |
| ADAR1 Capital Management, LLC 0.00% of their portfolio | 1.5k $1.4k | New |
| Key Financial Inc 0.00% of their portfolio | 830 $786 | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 692 $656 | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 366 $0 | Reduced -167 |
| UBS Group AG 0.00% of their portfolio | 201 $191 | Unchanged |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 118 $112 | Reduced -5.4k |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 4 $4 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |